Facebook

Overcoming Barriers to Access

Our objective is to lower the cost of medicines, vaccines and tests through competition, to ensure patents are not a barrier to access and to push back against harmful trade deals or entrenched industry interests.

5. December 2016.
|
EFTA

India–EFTA trade talks may make medicines more expensive

MSF and civil society urge Swiss negotiators not to undermine the ‘pharmacy of the developing world’. Read more

 

Access Barriers: The Issues

© Juan Carlos Tomasi

Learn about the major barriers to access to drugs, tests and vaccines that MSF is trying to break down.

» Read more

Featured multimedia

Kala Azar: Still Waiting
Some three decades ago, a mystery disease spread throughout Sudan and what is now South Sudan, decimating communities, sewing fear, and killing scores...

Tags: Sudan, kala azar, visceral leishmaniasis, neglected diseases, R&D

↑ To top